About

Dr. Reeder-Hayes is a health services researcher with a focus on quality and access to care among patients with breast cancer, as well as treatment adherence and the comparative effectiveness of cancer treatments in diverse populations. In addition to her clinical training as a medical oncologist specializing in breast cancer, her research training includes a masters’ degree in clinical research from the ºÚÁÏÍø School of Public Health and a post-doctoral fellowship in comparative effectiveness research from the ºÚÁÏÍø Sheps Center for Health Services Research. She has previously led Big Data analyses of race and age disparities in the receipt of breast cancer surgery, endocrine therapy initiation and adherence, use of HER2-directed therapy and use of gene expression profiling, and is the Medical Director of the ºÚÁÏÍø Cancer Informatics and Population Health Resource (CIPHR) linked data repository, where her lab focuses on how race and geography impact the quality and timeliness of cancer care. She has an extensive portfolio of research in the area of adherence to breast cancer endocrine therapy in HR+ breast cancer, and co-leads the national, R01-funded GETSET randomized control trial, testing a variety of technology-based interventions to improve adherence to endocrine therapy in breast cancer patients through the Alliance for Clinical Trials in Oncology. She is a national leader of organizations impacting breast cancer disparities, as past Chair of the American Society of Clinical Oncology (ASCO) Health Equity Committee and a member of the Alliance Health Disparities and Breast committees.